Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KNP2002 in common warts
NCT05896215Phase 2Completed
- Sponsor
- KinoPharma, Inc.
- Start
- Jun 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of KNP-2002 in common warts (4 arms), sponsored by KinoPharma, Inc. Primary endpoint: Change in wart area at 16 weeks. Started Jun 2023; status: completed.
02
Drugs
KNP-2002
03
Conditions
common warts
Beyond the preview
Go deeper on NCT05896215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05896215.